Our treatment focuses on hematopoietic cell transplantation (HCT) — a proven method for treating blood cancers and other diseases that affect the bone marrow. Commonly, these procedures are refered to as bone marrow transplants (BMT) because the cells were collected directly from inside the bone, which was more invasive. Today, medical advances allow these same cells to be collected from the bloodstream instead, making the process much less invasive for donor dogs. We will use BMT throughout our materials since it’s more widely recognized and understood. Both terms can be used interchangeably.
A bone marrow transplant (BMT) replaces damaged or diseased bone marrow with healthy cells, allowing the body to produce normal blood cells again. For dogs with blood cancers, this is the only curative treatment available. At CTAC, our team has extensive experience performing BMTs in both small and large dogs. These procedures are complex, but their outcomes are life-changing — giving many patients the chance for more time and better health.
Each transplant is carefully planned to meet the specific needs of the patient, beginning with the selection of the stem cell source.

Uses the patient’s own stem cells

Uses stem cells from a matched donor

While BMT carries some risks and requires a commitment from both owners and veterinary professionals, it remains one of the most promising treatments in the fight against blood cancers in dogs. BMT has seen increasing success rates over many decades. In fact, dogs have been the model for developing these treatments in humans for many years before it was available for client-owned pets. 
Success depends on factors like the dog's overall health, the type of cancer, the effectiveness of prior treatments, and the ability to find a donor. If you or your veterinarian has any questions about BMT, please contact us.